Literature DB >> 25538461

Anti-nuclear antibody expression in severe scrub typhus infection: preliminary observations.

John Victor Peter1, Mathew F Griffith2, John Antony Jude Prakash3, Anugragh Chrispal4, Kishore Pichamuthu1, George M Varghese4.   

Abstract

Entities:  

Year:  2014        PMID: 25538461      PMCID: PMC4265838          DOI: 10.4103/0974-777X.145260

Source DB:  PubMed          Journal:  J Glob Infect Dis        ISSN: 0974-777X


× No keyword cloud information.
Sir, Antinuclear antibody (ANA), although associated with autoimmune processes, is described in infections.[1] We assessed ANA positivity in severe scrub typhus infection and studied the relationship between ANA positivity and organ dysfunction and mortality. Consecutive patients admitted to the ICU with severe scrub typhus infection and consenting to participate underwent an ANA test. The study was approved by the Institutional Review Board. Scrub typhus was diagnosed by a positive scrub IgM ELISA (≥16 units) in the presence of a characteristic eschar or the exclusion of other causes of febrile illness. ANA was detected by immunofluorescence using a commercially available assay at a serum dilution of 1:100. The reactions were scored independently by two technologists as negative (no fluorescence), weak positive or 1+ to 4+ based on the intensity of fluorescence. Patients were treated with doxycycline (enteral) plus azithromycin (intravenous), as parenteral doxycycline is unavailable in our country. Those requiring organ support (ventilation, hemodynamic support, dialysis) were treated as per guidelines. Complications of ventilation and nosocomial infections were managed according to standard protocols. Demographic data, symptom duration, organ dysfunction, need for ventilation, ventilator-free days, length of hospital stay and hospital outcome were collected in pre-constructed data forms. Organ dysfunction was diagnosed if organ-specific SOFA score was ≥1.[2] Fisher's and t-test were used for analysis of dichotomous and continuous variables respectively using STATA® v11. Over 9 months, 40 patients aged (Mean ± SD) 35.9 ± 14.0 years and APACHE-II score of 23.2 ± 8.4, presented with symptoms for 8.5 ± 3.8 days. Sixteen patients (40%) tested ANA positive; a speckled pattern in 9 and weak ANA positivity in 7. Patients tested negative for ANA had higher admission creatinine (P = 0.03), organ dysfunction (P = 0.06) and mortality (P = 0.06), compared with those who tested positive. Age, gender, dyspnea, altered mental status, fever duration, presence of eschar and APACHE-II score were not different between those tested ANA positive and negative [Table 1]. Ventilatory need and ventilator-free days were similar in ANA-positive and -negative patients.
Table 1

Baseline characteristics and outcome data

Baseline characteristics and outcome data ANA expression in scrub typhus is not surprising as this phenomenon is reported in other infections. Positivity may be explained in two ways. ANA positivity may be a non-specific response to the rickettsial infection as occurs with other infections. Alternatively, it may indicate a specific immunologic response to the (infective) vasculitis or occur as a marker of vasculitis demonstrated on histopathology in scrub typhus infection.[3] The trend toward a negative association between ANA positivity and organ dysfunction and mortality is unexpected as ANA is generally a marker for worse prognosis.[4] Recent work suggests that ANA may have a dual role in promoting or inhibiting disease processes.[4] Interestingly, in septic shock, the presence of autoantibodies to high-mobility group-box 1 (HMGB-1), a type of ANA, is associated with increased survival, suggesting that the induction of autoantibodies by infection may be beneficial.[5] This implies that ANA may be involved in inducing immunological disturbances and also in attenuating them.[4] These observations warrant further investigation on the mechanism of ANA positivity in scrub typhus.
  5 in total

Review 1.  Antinuclear antibodies in rheumatic disease: a proposal for a function-based classification.

Authors:  D S Pisetsky
Journal:  Scand J Immunol       Date:  2012-09       Impact factor: 3.487

2.  Autoantibodies in malaria, tuberculosis and hepatitis B in a west African population.

Authors:  A O Adebajo; P Charles; R N Maini; B L Hazleman
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

3.  Emergence of autoantibodies to HMGB1 is associated with survival in patients with septic shock.

Authors:  Stéphanie Barnay-Verdier; Lakhdar Fattoum; Chloé Borde; Srini Kaveri; Sébastien Gibot; Vincent Maréchal
Journal:  Intensive Care Med       Date:  2011-02-26       Impact factor: 17.440

4.  The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Working Group on Sepsis related Problems of the ESICM.

Authors:  R Moreno; J L Vincent; R Matos; A Mendonça; F Cantraine; L Thijs; J Takala; C Sprung; M Antonelli; H Bruining; S Willatts
Journal:  Intensive Care Med       Date:  1999-07       Impact factor: 17.440

Review 5.  Scrub typhus: clinical, pathologic, and imaging findings.

Authors:  Yeon Joo Jeong; Suk Kim; Yeh Dae Wook; Jun Woo Lee; Kun-Il Kim; Sun Hee Lee
Journal:  Radiographics       Date:  2007 Jan-Feb       Impact factor: 5.333

  5 in total
  2 in total

1.  Systematic review of the scrub typhus treatment landscape: Assessing the feasibility of an individual participant-level data (IPD) platform.

Authors:  Kartika Saraswati; Brittany J Maguire; Alistair R D McLean; Sauman Singh-Phulgenda; Roland C Ngu; Paul N Newton; Nicholas P J Day; Philippe J Guérin
Journal:  PLoS Negl Trop Dis       Date:  2021-10-14

2.  Serum Soluble Vascular Cell Adhesion Molecule-1 Overexpression Is a Disease Marker in Patients with First-Time Diagnosed Antinuclear Antibodies: A Prospective, Observational Pilot Study.

Authors:  Mara Oleszowsky; Matthias F Seidel
Journal:  Biomed Res Int       Date:  2018-02-01       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.